150 related articles for article (PubMed ID: 28815651)
21. Experimental pharmacology of hirunorm: a novel synthetic peptide thrombin inhibitor.
Cirillo R; Lippi A; Subissi A; Agnelli G; Criscuoli M
Thromb Haemost; 1996 Sep; 76(3):384-92. PubMed ID: 8883275
[TBL] [Abstract][Full Text] [Related]
22. Factor XIIa inhibition by Infestin-4: in vitro mode of action and in vivo antithrombotic benefit.
Xu Y; Cai TQ; Castriota G; Zhou Y; Hoos L; Jochnowitz N; Loewrigkeit C; Cook JA; Wickham A; Metzger JM; Ogletree ML; Seiffert DA; Chen Z
Thromb Haemost; 2014 Apr; 111(4):694-704. PubMed ID: 24336918
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic Potential of Resveratrol in COVID-19-Associated Hemostatic Disorders.
Giordo R; Zinellu A; Eid AH; Pintus G
Molecules; 2021 Feb; 26(4):. PubMed ID: 33562030
[TBL] [Abstract][Full Text] [Related]
24. Global Thrombosis Test (GTT) can detect major determinants of haemostasis including platelet reactivity, endogenous fibrinolytic and thrombin generating potential.
Yamamoto J; Inoue N; Otsui K; Ishii H; Gorog DA
Thromb Res; 2014 May; 133(5):919-26. PubMed ID: 24613697
[TBL] [Abstract][Full Text] [Related]
25. Interruption of thrombosis and hemostasis by anti-platelet agents.
Shebuski RJ
Toxicol Pathol; 1993; 21(2):180-9. PubMed ID: 8210940
[TBL] [Abstract][Full Text] [Related]
26. [Peptides as inhibitors of thrombin coagulation activity and of thrombocyte aggregation].
Pastorova VE; Liapina LA; Cherkasova KA; Ashmarin IP
Usp Fiziol Nauk; 1999; 30(2):80-91. PubMed ID: 10420478
[TBL] [Abstract][Full Text] [Related]
27. Current use of biologicals in thrombosis and haemostasis.
Ofosu FA; Barrowcliffe TW
Thromb Haemost; 2008 May; 99(5):805-6. PubMed ID: 18449409
[No Abstract] [Full Text] [Related]
28. Current antithrombotic agents for acute coronary syndromes: focus on bleeding risk.
Bassand JP
Int J Cardiol; 2013 Feb; 163(1):5-18. PubMed ID: 22100180
[TBL] [Abstract][Full Text] [Related]
29. BMS-593214, an active site-directed factor VIIa inhibitor: enzyme kinetics, antithrombotic and antihaemostatic studies.
Wong PC; Luettgen JM; Rendina AR; Kettner CA; Xin B; Knabb RM; Wexler R; Priestley ES
Thromb Haemost; 2010 Aug; 104(2):261-9. PubMed ID: 20589312
[TBL] [Abstract][Full Text] [Related]
30. Cytokines and hemostasis.
Grignani G; Maiolo A
Haematologica; 2000 Sep; 85(9):967-72. PubMed ID: 10980636
[TBL] [Abstract][Full Text] [Related]
31. In vitro methods of evaluating antithrombotics and thrombolytics.
Mousa SA
Methods Mol Biol; 2010; 663():1-28. PubMed ID: 20617413
[TBL] [Abstract][Full Text] [Related]
32. Vitamins and minerals that affect hemostasis and antithrombotic therapies.
Rebecca Couris R
Thromb Res; 2005; 117(1-2):25-31; discussion 39-42. PubMed ID: 16257439
[No Abstract] [Full Text] [Related]
33. [Mechanism of thrombosis: physiopathology, role of thrombin and its inhibition by modern therapies].
Hamon M
Arch Mal Coeur Vaiss; 2006 Feb; 99 Spec no.3():5-9. PubMed ID: 16553237
[TBL] [Abstract][Full Text] [Related]
34. Current perspectives in the treatment of thrombotic disorders.
Drouet L; Caen JP
Semin Thromb Hemost; 1989 Apr; 15(2):111-22. PubMed ID: 2665082
[TBL] [Abstract][Full Text] [Related]
35. FXIIa inhibitor rHA-Infestin-4: Safe thromboprotection in experimental venous, arterial and foreign surface-induced thrombosis.
May F; Krupka J; Fries M; Thielmann I; Pragst I; Weimer T; Panousis C; Nieswandt B; Stoll G; Dickneite G; Schulte S; Nolte MW
Br J Haematol; 2016 Jun; 173(5):769-78. PubMed ID: 27018425
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of polyphosphate as a novel strategy for preventing thrombosis and inflammation.
Smith SA; Choi SH; Collins JN; Travers RJ; Cooley BC; Morrissey JH
Blood; 2012 Dec; 120(26):5103-10. PubMed ID: 22968458
[TBL] [Abstract][Full Text] [Related]
37. Hemostasis and coagulation monitoring and management during liver transplantation.
Dalmau A; Sabaté A; Aparicio I
Curr Opin Organ Transplant; 2009 Jun; 14(3):286-90. PubMed ID: 19300254
[TBL] [Abstract][Full Text] [Related]
38. International Society of Thrombosis and Hemostasis--XIXth Congress 12-18 July 2003, Birmingham, UK.
Shah S
IDrugs; 2003 Sep; 6(9):858-61. PubMed ID: 14565174
[No Abstract] [Full Text] [Related]
39. Coagulopathy in liver disease: a balancing act.
Kujovich JL
Hematology Am Soc Hematol Educ Program; 2015; 2015():243-9. PubMed ID: 26637729
[TBL] [Abstract][Full Text] [Related]
40. Antithrombotic strategies targeting thrombin activities, thrombin receptors and thrombin generation.
Harker LA; Hanson SR; Kelly AB
Thromb Haemost; 1997 Jul; 78(1):736-41. PubMed ID: 9198248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
